Israel Lipid POCT Market to 2032

Overview

The Israel Lipid POCT Market is expected to reach a 0.51 USD Million by 2032 and is projected to grow at a CAGR of 3.80% from 2025 to 2032.

Revenue, 2024 (USD Million)
0.42
Forecast, 2032 (USD Million)
0.51
CAGR, 2024 - 2032
3.80%
Report Coverage
Israel

Israel Lipid POCT Market 2018-2032 USD Million

Israel Lipid POCT Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 0.42 USD Million
  • Projected Market Size (2032): 0.51 USD Million
  • CAGR (2025-2032): 3.80%

Key Findings of Israel Lipid POCT Market

  • The Israel Lipid POCT Market was valued at 0.42 USD Million in 2024.
  • The Israel Lipid POCT Market is likely to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Prescription-Based Testing in Mode Segment accounted for the largest share of the market with a revenue of 0.34 USD Million
  • The fastest growing segment Hypertriglyceridemia in Application Segment grew Fastest with a CAGR of 7.17% during the forecast period from 2024 to 2032.

Israel Lipid POCT Market Scope

Israel Lipid POCT Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tenders
End User
  • Other End Users
  • Research Laboratories
  • Home Care
  • Professional Diagnostic Centers
  • Hospitals
Application
  • Others
  • Tangier Disease
  • Familial Hypercholesterolemia
  • Hyperlipoproteinemia
  • Hypertriglyceridemia
  • Hyperlipidemia
Mode
  • OTC-Based Testing
  • Prescription-Based Testing
Brand
  • PTS Cardiochek
  • Alere Afinion
  • Alere Cholestech LDX
  • Others
  • Roche Cobas B 101
  • Roche Reflotron
Platform
  • Microfluidics
  • Dipsticks
  • Immunoassays
  • Molecular Diagnostics
  • Lateral Flow Assays /Immunochromatography Tests
Type
  • Consumables And Kits
  • Instruments

Israel Lipid POCT Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 0.42 USD Million
Market Value in 2032 0.51 USD Million
CAGR (2025-2032) 3.80%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Application,Mode,Brand,Platform,Type

Regional Insights:

  • Leading Market (2024-2032): Israel, leading in terms of revenue 0.42 USD Million in 2024
    • Key Country: Israel, leading in terms of revenue with value of 0.42 USD Million in 2024.

Segments and Scope

  • Israel Lipid POCT Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.26 USD Million in the year 2024.
    • Retail Sales is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 3.48 % in forecast period 2025-2032.
  • Israel Lipid POCT Market to 2032, By End User
    • Professional Diagnostic Centers is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.13 USD Million in the year 2024.
    • Professional Diagnostic Centers is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 4.75 % in forecast period 2025-2032.
  • Israel Lipid POCT Market to 2032, By Application
    • Hyperlipidemia is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.26 USD Million in the year 2024.
    • Hypertriglyceridemia is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 3.04 % in forecast period 2025-2032.
  • Israel Lipid POCT Market to 2032, By Mode
    • Prescription-Based Testing is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.34 USD Million in the year 2024.
    • OTC-Based Testing is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 3.43 % in forecast period 2025-2032.
  • Israel Lipid POCT Market to 2032, By Brand
    • Roche Reflotron is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.22 USD Million in the year 2024.
    • Roche Cobas B 101 is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 4.45 % in forecast period 2025-2032.
  • Israel Lipid POCT Market to 2032, By Platform
    • Molecular Diagnostics is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.13 USD Million in the year 2024.
    • Molecular Diagnostics is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 4.75 % in forecast period 2025-2032.
  • Israel Lipid POCT Market to 2032, By Type
    • Instruments is the largest segment in Israel Lipid POCT Market to 2032 with a revenue of 0.25 USD Million in the year 2024.
    • Consumables And Kits is the Fastest growing segment in Israel Lipid POCT Market to 2032 with a Growth rate of 2.96 % in forecast period 2025-2032.

Israel Lipid POCT Market Company Share Analysis

 
Company Name Company Share Analysis
Quest Diagnostics Incorporated
Abbott
A. Menarini Diagnostics s.r.l
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Israel Lipid POCT Market Company Share Analysis

Israel Lipid POCT Market Geographical Sales Distribution, 2018-2032 USD Million

Israel Lipid POCT Market Geographical Sales Distribution, 2018-2032 USD Million

Israel Lipid POCT Market Company Profiling

Israel Lipid POCT Market Company Profiling
Frequently Asked Questions
The Israel Lipid POCT Market is segmented based on Segmentation Distribution Channel,End User,Application,Mode,Brand,Platform,Type.
Israel Lipid POCT Market was valued at USD 0.42(Revenue in USD Million) in 2020.
Israel Lipid POCT Market is projected to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the Israel Lipid POCT Market, holding a largest market share of 0.34 USD Million in 2024

Israel Lipid POCT Market Scope

Israel Lipid POCT Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tenders
End User
  • Other End Users
  • Research Laboratories
  • Home Care
  • Professional Diagnostic Centers
  • Hospitals
Application
  • Others
  • Tangier Disease
  • Familial Hypercholesterolemia
  • Hyperlipoproteinemia
  • Hypertriglyceridemia
  • Hyperlipidemia
Mode
  • OTC-Based Testing
  • Prescription-Based Testing
Brand
  • PTS Cardiochek
  • Alere Afinion
  • Alere Cholestech LDX
  • Others
  • Roche Cobas B 101
  • Roche Reflotron
Platform
  • Microfluidics
  • Dipsticks
  • Immunoassays
  • Molecular Diagnostics
  • Lateral Flow Assays /Immunochromatography Tests
Type
  • Consumables And Kits
  • Instruments
Frequently Asked Questions
The Israel Lipid POCT Market is segmented based on Segmentation Distribution Channel,End User,Application,Mode,Brand,Platform,Type.
Israel Lipid POCT Market was valued at USD 0.42(Revenue in USD Million) in 2020.
Israel Lipid POCT Market is projected to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Lipid POCT Market for final year is USD 0.51 (USD Million).

Israel Lipid POCT Market Company Profiling

Israel Lipid POCT Market Company Profiling
Frequently Asked Questions
The Israel Lipid POCT Market is segmented based on Segmentation Distribution Channel,End User,Application,Mode,Brand,Platform,Type.
Israel Lipid POCT Market was valued at USD 0.42(Revenue in USD Million) in 2020.
Israel Lipid POCT Market is projected to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Lipid POCT Market for final year is USD 0.51 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.